Search research articles
Contact Us
Filters
Showing results (121-130 of 178) with videos related to
Page
of 18
Sort By:
European Journal of Endocrinology
|
October 27, 2015
Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome
Alicia Santos, Eugenia Resmini, Beatriz Gómez-Ansón, et al.
European Journal of Endocrinology
|
February 5, 2015
MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies
Cornelie D Andela, Femke M van Haalen, Oskar Ragnarsson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2002
Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database
Andrea F Attanasio, Peter C Bates, Ken K Y Ho, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 2025
Melatonin as a possible stimulus to unmask an oxytocin deficient state in hypopituitarism and hypothalamic damage
Queralt Asla, Maite Garrido, Eulàlia Urgell, et al.
Plos One
|
August 16, 2014
Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?
Jordi L Reverter, Carmen Fajardo, Eugenia Resmini, et al.
Endocrine Connections
|
April 11, 2025
Quality of life and psychological status in people with acromegaly in relation to facial changes
Maria Antonia Martínez-Momblan, Sergio Alonso-Fernández, Montserrat Marques-Pamies, et al.
Clinical Drug Investigation
|
March 9, 2012
Cost of clinical management of acromegaly in Spain
Montse Roset, Sandra Merino-Montero, Manuel Luque-Ramírez, et al.
European Journal of Endocrinology
|
April 25, 2014
Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease
Susan M Webb, John E Ware, Anna Forsythe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2012
Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY
A J van der Lely, Beverly M K Biller, Thierry Brue, et al.
European Journal of Endocrinology
|
October 17, 2018
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
Michael Buchfelder, Aart-Jan van der Lely, Beverly M K Biller, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 178) with videos related to
Sort By:
Page
of 18
European Journal of Endocrinology
|
October 27, 2015
Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome
Alicia Santos, Eugenia Resmini, Beatriz Gómez-Ansón, et al.
European Journal of Endocrinology
|
February 5, 2015
MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies
Cornelie D Andela, Femke M van Haalen, Oskar Ragnarsson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2002
Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database
Andrea F Attanasio, Peter C Bates, Ken K Y Ho, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 2025
Melatonin as a possible stimulus to unmask an oxytocin deficient state in hypopituitarism and hypothalamic damage
Queralt Asla, Maite Garrido, Eulàlia Urgell, et al.
Plos One
|
August 16, 2014
Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?
Jordi L Reverter, Carmen Fajardo, Eugenia Resmini, et al.
Endocrine Connections
|
April 11, 2025
Quality of life and psychological status in people with acromegaly in relation to facial changes
Maria Antonia Martínez-Momblan, Sergio Alonso-Fernández, Montserrat Marques-Pamies, et al.
Clinical Drug Investigation
|
March 9, 2012
Cost of clinical management of acromegaly in Spain
Montse Roset, Sandra Merino-Montero, Manuel Luque-Ramírez, et al.
European Journal of Endocrinology
|
April 25, 2014
Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease
Susan M Webb, John E Ware, Anna Forsythe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2012
Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY
A J van der Lely, Beverly M K Biller, Thierry Brue, et al.
European Journal of Endocrinology
|
October 17, 2018
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
Michael Buchfelder, Aart-Jan van der Lely, Beverly M K Biller, et al.
Page
of 18